The global Endoprosthesis Market is estimated to be valued at US$ 21.50 billion in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Endoprostheses are medical devices that are used to replace or support a damaged or diseased joint in the body. They are commonly used in orthopedic surgeries to improve the mobility and quality of life for patients suffering from conditions such as arthritis or joint degeneration. The market for endoprostheses is driven by the increasing prevalence of chronic diseases and the growing geriatric population worldwide. Additionally, advancements in technology have led to the development of innovative endoprosthetic implants with improved durability and functionality.
Market Key Trends:
One key trend in the endoprosthesis market is the growing adoption of minimally invasive surgical techniques. Minimally invasive procedures offer several advantages such as reduced post-operative pain, faster recovery times, and smaller incisions, resulting in better patient outcomes. These procedures also minimize the risk of infection and reduce hospital stays, leading to cost savings for patients and healthcare providers. The growing focus on patient-centric care and the increasing demand for less invasive treatment options are driving the adoption of minimally invasive surgeries, thereby fueling the growth of the endoprosthesis market.
Porter’s Analysis
Threat of new entrants: The Endoprosthesis Market poses a moderate threat to new entrants. While the market is highly lucrative with a forecasted growth rate of 7.5% CAGR over the period from 2023 to 2030, it is also characterized by high barriers to entry. Established key players have already established strong brand recognition, distribution networks, and extensive research and development capabilities, making it difficult for new entrants to compete effectively.
Bargaining power of buyers: The bargaining power of buyers in the endoprosthesis market is moderate. While buyers have a wide range of options to choose from due to the presence of several key players, the critical nature of endoprosthesis products limits their ability to negotiate significantly lower prices. Additionally, the high switching costs for buyers also reduce their bargaining power.
Bargaining power of suppliers: Suppliers in the endoprosthesis market have a moderate level of bargaining power. Key players in this market require a steady supply of high-quality materials, such as metals, polymers, and ceramics, to manufacture endoprosthesis products. However, the presence of multiple suppliers and the ability of key players to switch suppliers if necessary limits the bargaining power of any single supplier.
Threat of new substitutes: The threat of new substitutes in the endoprosthesis market is relatively low. Endoprosthesis products, such as hip and knee replacements, are essential and widely accepted medical treatments, with no viable substitutes currently available. The high success rates and patient satisfaction associated with endoprosthesis procedures further reduce the likelihood of new substitutes emerging.
Competitive rivalry: The competitive rivalry in the endoprosthesis market is intense. Key players, such as Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson, compete fiercely to gain market share and maintain their competitive edge. This intense competition is driven by factors such as technological advancements, product innovation, and the need to capture a larger share of the growing endoprosthesis market.
Key Takeaways
The global endoprosthesis market is expected to witness high growth, exhibiting a CAGR of 7.5% over the forecast period from 2023 to 2030. This growth is primarily driven by the increasing prevalence of chronic diseases, such as osteoarthritis and cardiovascular diseases, which necessitate the use of endoprosthesis products. Additionally, the expanding geriatric population and growing awareness about the benefits of endoprosthesis procedures are further contributing to market growth.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the endoprosthesis market. The region's strong healthcare infrastructure, high disposable income, and favorable reimbursement policies are driving the demand for endoprosthesis products. Furthermore, the presence of major key players and ongoing technological advancements in the region are also contributing to its growth.
Key players operating in the endoprosthesis market include Medtronic, Boston Scientific, Abbott Laboratories, Edwards Lifesciences, Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, BD, and Teleflex. These key players have established themselves as industry leaders with a strong market presence and extensive product portfolios. Their focus on research and development, strategic partnerships, and mergers and acquisitions has helped them maintain their competitive advantage in the market.
Aug 17, 2020: The global blood collection market size is expected to reach a value of USD 13.99 billion by 2026, expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc.
Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period.According to the World Health Organization, over 41 million individuals that are equivalent to almost 71% of global deaths were caused due to non-communicable diseases in 2018.
Cardiovascular diseases registered the highest mortality rates of over 17.9 million followed by cancer that claimed 9 million deaths and respiratory diseases such as chronic obstructive pulmonary disease & asthma claimed over 3.9 million lives in 2017 globally.
These facts are indicative of an increase in the incidence of non-communicable diseases, which is expected to fuel market growth.Download sample Copy of This Report at: https://www.radiantinsights.com/research/blood-collection-market/request-sampleAn increase in the number of road accidents is anticipated to lead to a rise in demand for blood and its components.
According to the National Trauma Institute, trauma injuries account for 30% of lives lost globally.
Statistics from the same source indicate that trauma is the number one cause of death from the age of 1 to 46.
The global methyl methacrylate market size is projected to reach USD 23.45 million by the end of 2027.
The increasing applications of the product across diverse industry verticals will emerge in favor of market growth.https://www.fortunebusinessinsights.com/methyl-methacrylate-mma-market-103295
